Kenny Walter

In a new cohort study, investigators examine the link between blood pressure and cognitive decline.

The new FDA approval allows physicians to administer EYLEA in a prefilled syringe to treat retinal conditions with fewer preparation steps than vials.

Investigators find that ADHD drug MPH impacts the brain differently depending on age.

In a new trial with 35 healthy women, investigators find that a novel vaccine could effectively and safely treat chlamydia.

In a new multivariable regression study, investigators link depression with a lack of social support and increased IBD activity.

Survey responses from 700 Parkinson disease patients and their caregivers show a majority of patients report problems with non-motor symptoms.

A further examination of data from a research clinical database shows the risk of smoking outweigh any potential benefits for UC patients.

Early exposure to C. difficile helps infants stave off infection later in life.

Investigators in a new cohort study examine social, functional, and medical characteristics for dementia patients living at home, in residential care, and in a nursing home facility.

Alkahest announces positive top-line data for phase 2 study to treat mild-to-moderate Alzheimer disease.

The majority of physicians in a new survey support hiring additional support staff in an effort to alleviate burnout symptoms.

Socially active people in the their 50s and 60s have a lower risk of developing dementia, according to a new study.

New model predicts patients at risk of developing Alzheimer disease up to 2 years in the future.

Investigators find improved liver function in hepatocellular carcinoma patients tied to aspirin use in a new retrospective review.

Proof-of-concept study follows patients who receive a HCV-positive donor heart.

A conventional mass-univariate fMRI analysis helps determine patients that exhibit greater pretreatment neural activity.

New study links serum-based liver function markers with known Alzheimer disease biomarkers.

FDA announces 137 new drug approvals in 2018 represents an 11% increase over 2017.

Sunovion seeking FDA approval for dateline after successful clinical trials treating binge eating disorder.

A cohort study analysis shows clozapine is effective in treating schizophrenia, despite adverse effects.

Just 2 weeks of therapy could help attenuated autonomic function for geriatric adults.

Investigators analyze impact of needle and syringe, hepatitis C elimination program in the country of Georgia.

New study identifies average cost and hospital length increase for hospital-acquired C. difficile.

The fourth version of the Cleveland Clinic’s Alzheimer pipeline includes 156 clinical trials and 132 agents currently in all 3 phases of clinical trials in the US.

New study breaks down initial antipsychotic prescriptions among young, ADHD patients.

Both motor and non-motor symptoms improve using ear stimulation can help manage Parkinson symptoms.

New research shows esketamine nasal spray could help treat patients who do not respond to antidepressants.

Older patients could benefit from skipping traditional bedrest in favor of an exercise program when hospitalized with an acute illness.

New research finds association common sleep disorder present in 14% of suicidal patients with major depressive disorder studied.

Guidelines include combination of vaccines, screenings and case management to prevent hepatitis B from infecting infants.